Related Experiment Video
Updated: Jun 12, 2026

08:50
A Nonsequencing Approach for the Rapid Detection of RNA Editing
Published on: April 21, 2022
Adenosine-to-inosine RNA editing shapes transcriptome diversity in primates
Nurit Paz-Yaacov1, Erez Y Levanon, Eviatar Nevo
1Cancer Research Center, Chaim Sheba Medical Center, Tel Hashomer 52621, Israel.
Summary
Human brain evolution may be linked to increased RNA editing in primate-specific Alu sequences. This adenosine-to-inosine (A-to-I) RNA editing, particularly in the human brain, might contribute to higher cognitive functions.
Area of Science:
- Genomics
- Neuroscience
- Molecular Biology
Background:
- Human and chimpanzee genomes are highly similar, yet humans exhibit superior cognitive abilities.
- Adenosine-to-inosine (A-to-I) RNA editing is a prevalent transcriptome modification, with higher levels observed in humans compared to nonprimates, especially within primate-specific Alu sequences.
- The global RNA editing levels in nonhuman primates remain largely uncharacterized.
Purpose of the Study:
- To investigate and compare the global RNA editing levels in Alu sequences across humans, chimpanzees, and rhesus monkeys.
- To explore the potential role of A-to-I RNA editing in the development of higher brain functions in humans.
Main Methods:
- Sequencing of transcribed Alu sequences in humans, chimpanzees, and rhesus monkeys.
- Comparative analysis of RNA editing levels in brain tissues.
- Identification and analysis of species-specific Alu insertions and their association with neuronal genes.
Main Results:
- The average RNA editing level in analyzed transcripts is higher in the human brain compared to nonhuman primates, even in unmodified genomic Alu structures.
- Correlated editing patterns were observed for specific adenosine sites within Alu sequences.
- Post-human-chimpanzee split, new editable, species-specific Alu insertions are significantly enriched in genes associated with neuronal functions and neurological diseases.
Conclusions:
- Enhanced A-to-I RNA editing in the human brain, particularly within Alu sequences, may contribute to the evolution of higher cognitive functions.
- Combinatorial editing significantly expands the transcriptome repertoire.
- Alu editing, potentially shaped by natural selection, could function as an alternative information system using an A/I binary code.
Related Concept Videos
RNA Editing
RNA editing is a post-transcriptional modification where a precursor mRNA (pre-mRNA) nucleotide sequence is changed by base insertion, deletion, or modification. The extent of RNA editing varies from a few hundred bases, in mitochondrial DNA of trypanosomes, to a just single base, in nuclear genes of mammals. Even a single base change in the pre-mRNA can convert a codon for one amino acid into the codon for another amino acid or a stop codon. This type of re-coding can significantly affect the...
pre-mRNA Processing
In eukaryotic cells, transcripts made by RNA polymerase are modified and processed before exiting the nucleus. Unprocessed RNA is called precursor mRNA or pre-mRNA to distinguish it from mature mRNA.
Once about 20-40 ribonucleotides have been joined together by RNA polymerase, a group of enzymes adds a “cap” to the 5’ end of the growing transcript. In this process, a 5’ phosphate is replaced by modified guanosine that has a methyl group attached to it (7-Methyl guanosine). This 5’ cap helps the...
Once about 20-40 ribonucleotides have been joined together by RNA polymerase, a group of enzymes adds a “cap” to the 5’ end of the growing transcript. In this process, a 5’ phosphate is replaced by modified guanosine that has a methyl group attached to it (7-Methyl guanosine). This 5’ cap helps the...
Pre-mRNA Processing
In eukaryotic cells, transcripts made by RNA polymerase are modified and processed before exiting the nucleus. Unprocessed RNA is called precursor mRNA or pre-mRNA to distinguish it from mature mRNA.
Once about 20-40 ribonucleotides have been joined together by RNA polymerase, a group of enzymes adds a “cap” to the 5’ end of the growing transcript. In this process, a 5’ phosphate is replaced by modified guanosine that has a methyl group attached to it (7-Methyl guanosine). This 5’ cap helps the...
Once about 20-40 ribonucleotides have been joined together by RNA polymerase, a group of enzymes adds a “cap” to the 5’ end of the growing transcript. In this process, a 5’ phosphate is replaced by modified guanosine that has a methyl group attached to it (7-Methyl guanosine). This 5’ cap helps the...
Experimental RNAi
RNA interference (RNAi) is a cellular mechanism that inhibits gene expression by suppressing its transcription or activating the RNA degradation process. The mechanism was discovered by Andrew Fire and Craig Mello in 1998 in plants. Today, it is observed in almost all eukaryotes, including protozoa, flies, nematodes, insects, parasites, and mammals. This precise cellular mechanism of gene silencing has been developed into a technique that provides an efficient way to identify and determine the...
Pre-mRNA Processing: Modification of pre-mRNA Ends
In eukaryotic cells, transcripts made by RNA polymerase are modified and processed before exiting the nucleus. Unprocessed RNA is called precursor mRNA or pre-mRNA to distinguish it from mature mRNA.
Once about 20-40 ribonucleotides have been joined together by RNA polymerase, a group of enzymes adds a cap to the 5' end of the growing transcript. In this process, a 5' phosphate is replaced by modified guanosine that has a methyl group attached (7-methyl guanosine). This 5' cap helps the cell...
Once about 20-40 ribonucleotides have been joined together by RNA polymerase, a group of enzymes adds a cap to the 5' end of the growing transcript. In this process, a 5' phosphate is replaced by modified guanosine that has a methyl group attached (7-methyl guanosine). This 5' cap helps the cell...
RNA Interference
RNA interference (RNAi) is a process in which a small non-coding RNA molecule blocks the post-transcriptional expression of a gene by binding to its messenger RNA (mRNA) and preventing the protein from being translated.
This process occurs naturally in cells, often through the activity of genomically-encoded microRNAs. Researchers can take advantage of this mechanism by introducing synthetic RNAs to deactivate specific genes for research or therapeutic purposes. For example, RNAi could be used...
This process occurs naturally in cells, often through the activity of genomically-encoded microRNAs. Researchers can take advantage of this mechanism by introducing synthetic RNAs to deactivate specific genes for research or therapeutic purposes. For example, RNAi could be used...

